Scientists should use methods of cloning of individual human cells because it provides benefits of curing diseases and regrowth of damaged organs or tissues. However, scientists should not clone whole adult human beings because of the violation of moral, ethical, and religious concerns. Hence, scientists must separate making spare body parts from making whole people. Therapeutic cloning is a procedure, which an ovum is removed and replaced with the DNA from a cell removed from a patient. Then the ovum is fertilized by a jolt of electricity, and is now called a pre-embryo with the intent of producing tissue or a whole organ for transplant back into the person who supplied the DNA. The pre-embryo dies in the process (Utton 2004:32 News Paper). The goal of therapeutic cloning is to pr

This technique would be vastly superior to relying on organ transplants from other people, as the tissue match is identical so rejection is not an issue (Utton 2004:32 News Paper). The supply could be unlimited, so there would be no waiting lists. At present there are more potential recipients for transplanted organs than the available supply (Stolar 2002:Internet). The tissue or organ would have the sick person's original DNA and the patient would not have to take drugs like immunosuppressants for the rest of their life as is now required after transplants, there would not be any danger of organ rejection. Immunosuppressants are drugs that dampen the immune system so that white blood cells will not attack and reject the foreign tissue resulting in transplant failure. Immunosuppressants are associated with the risks of infection and cancers (Hazelton 2004: Interview). Therapeutic Cloning is safer than organ transplants.

oduce a healthy copy of a sick person's tissue or organ for transplant.

Many people in other countries cannot afford medical treatment. It costs on average $60,000 a year for someone to under go renal dialysis (Hazelton 2004: Interview), plus the patient cannot work. But it only costs about $100,000 for a kidney transplant operation (Hazelton 2004: Interview), so after eighteen mon

Some topics in this essay:
Therapeutic Cloning, , Paper Furthermore, therapeutic cloning, hazelton 2004 interview, hazelton 2004, tissue organ, 2004 interview, contribute society, utton 200432 paper, artificial kidney treatment, embryos positive technology, waiting lists, sick people, tissue organ transplant, 200453 paper, spare beds, kidney failure,